Howard Robin
Chief Executive Officer bei NEKTAR THERAPEUTICS
Vermögen: 822 199 $ am 31.03.2024
Profil
Howard W.
Robin is currently the President, Chief Executive Officer & Director at Nektar Therapeutics since 2007.
He is also a Trustee at Fairleigh Dickinson University.
Previously, he served as the President, Chief Executive Officer & Director at Sirna Therapeutics, Inc. from 2001 to 2006.
Prior to that, he was the Director-Business Planning & Development at Berlex, Inc. from 1987 to 2001.
He has also held positions as a Director at Acologix, Inc., Biotechnology Innovation Organization, and The Bay Area Bioscience Association.
Additionally, he worked as a Senior Associate at Arthur Andersen LLP.
From 1991 to 2001, he served as the Vice President & General Manager at Berlex Laboratories, Inc. Mr. Robin obtained his undergraduate degree from Fairleigh Dickinson University in 1974.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEKTAR THERAPEUTICS
0,48% | 20.02.2024 | 880 299 ( 0,48% ) | 822 199 $ | 31.03.2024 |
Aktive Positionen von Howard Robin
| Unternehmen | Position | Beginn |
|---|---|---|
| NEKTAR THERAPEUTICS | Chief Executive Officer | 01.01.2007 |
| Fairleigh Dickinson University | Director/Board Member | - |
Ehemalige bekannte Positionen von Howard Robin
| Unternehmen | Position | Ende |
|---|---|---|
Sirna Therapeutics, Inc.
 Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Chief Executive Officer | 01.11.2006 |
Berlex, Inc.
 Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Corporate Officer/Principal | - |
| Berlex Laboratories, Inc. | Director of Finance/CFO | 01.01.1991 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
| The Bay Area Bioscience Association | Director/Board Member | - |
Ausbildung von Howard Robin
| Fairleigh Dickinson University | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEKTAR THERAPEUTICS | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Sirna Therapeutics, Inc.
Sirna Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sirna Therapeutics, Inc. creates potent and stable siRNA compounds that are delivered into human cells resulting in the silencing of genes and viruses responsible for human diseases. The firm creates RNAi- based therapies to treat patients. The company was founded in 1992 and is headquartered in San Francisco, CA. | Commercial Services |
Berlex, Inc.
Berlex, Inc. Pharmaceuticals: MajorHealth Technology Berlex, Inc. manufactured pharmaceutical company. It developed novel diagnostics and therapeutics, which address unmet medical needs. It used to researches, develops, manufactures and markets ethical pharmaceuticals in five strategic areas such as female healthcare, diagnostic imaging, dermatology, oncology and therapeutics. The company was headquartered in Wayne, NJ | Health Technology |
Acologix, Inc.
 Acologix, Inc. Pharmaceuticals: MajorHealth Technology Acologix, Inc. develops and commercializes medicines. The company was founded by Yoshinari Kumagai in 1992 and is headquartered in Hayward, CA. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Arthur Andersen LLP
 Arthur Andersen LLP Miscellaneous Commercial ServicesCommercial Services Arthur Andersen LLP used to provide accounting services. It was also into consulting services for clients that operate businesses throughout the United States and around the world. Arthur Andersen was founded in 1913 and was headquartered in Chicago, IL. | Commercial Services |
| The Bay Area Bioscience Association | Health Technology |
| Berlex Laboratories, Inc. |
